Compare Globus Medical Inc. Class A Common Stock (GMED) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Microchip Technology Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Microchip Technology Inc. trades at $70.28 (market cap $38.69B). The key difference: Microchip Technology Inc. is far larger — about 3.8× Globus Medical Inc. Class A Common Stock's market cap, and Microchip Technology Inc. pays a 2.55% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Microchip Technology Inc. for 63 Days on average.
| GMED | MCHP | |
|---|---|---|
Market Cap | $10.25B | $38.69B |
Volume | 1,059,528 | 14,380,005 |
Sector | Health | Technology |
52-Week High | $96.82 | $102.97 |
52-Week Low | $58.33 | $49.02 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $9.76B | $43.82B |
Dividend Yield | — | 2.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Microchip Technology (MCHP) trades at $74.16, up 0.45% on the day, with a bearish technical signal but strong analyst consensus. The company has beaten EPS estimates for the last three quarters, though 2025 saw a net loss amid revenue contraction. Recent news highlights expansion in Ethernet and 48V power portfolios, along with the completed acquisition of Hailo, targeting growth in automotive, industrial, and AI infrastructure markets.
The outlook is mixed: robust buy-side analyst support and strategic positioning in high-growth sectors offer upside potential, but high valuation multiples, significant debt, and recent profitability challenges present risks. The consensus price target of $110.50 implies substantial appreciation, contingent on successful execution and market demand recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
